Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Finasteride exposure harms tadpole reproduction and hormone balance.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Hair loss in men is common, treatable, but not curable.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Hair loss in men treated best with early medication or transplant, new treatments researched.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Combining minoxidil and spironolactone is more effective for female hair loss, but minoxidil alone is sufficient after 6 months.

Effective acne management in PCOS includes hormone therapy, metformin, isotretinoin, weight loss, diet, exercise, and personalized treatment plans.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

Finasteride reduces prostate size and PSA levels in young patients.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

The exact causes of baldness are not fully understood, limiting treatment options.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Hair transplant surgery is a good cosmetic solution for people with little or no pubic hair, especially to boost their self-esteem.

Certain drugs that block specific enzymes can help treat prostate diseases.